bpc-157 clinical trials human randomized A-H. Gross presentation of injury severity. A poor course in all BPC-157 and Healing Peptides: Hype
Description
The administration of 48 IU IN-OXT to SZ patients and age-matched controls followed by facial emotion matching and control tasks failed to show any improvement in facial affect processing, contradicting previous results with IN-OXT [166]
BPC-157s broad pre-clinical activity across gut, tendon, muscle, nerve, bone, and vascular tissue has been a subject of significant mechanistic interest in the research literature
10.1038/mt.2009.146
Cyanocobalamin | Drugs | BNF NICE
